--- title: Press Releases | CancerIQ (2) description: View our latest news and press from CancerIQ. (2) --- [![CancerIQ Logo](https://blog.canceriq.com/hubfs/CancerIQ-July2016-Images/CancerIQ_Logo_AL_03-e1445848522956.png)](https://www.canceriq.com/) [![](https://blog.canceriq.com/hubfs/CancerIQ-July2016-Images/CancerIQ_Logo_AL_03-e1445848522956.png)](https://www.canceriq.com/) ** Our Locations Chicago ** Email Address info@cancer-iq.com ## [CancerIQ CEO, Feyi Olopade featured Alumni at St. Paul's School](https://blog.canceriq.com/press/canceriq-ceo-feyi-olopade-featured-alumni-at-st.-pauls-school) [![](https://blog.canceriq.com/hubfs/DSC_0407.jpg) ](https://blog.canceriq.com/press/canceriq-ceo-feyi-olopade-featured-alumni-at-st.-pauls-school) **November 25, 2016-** What if, as part of your routine well visit to your primary care physician, you could track your predispositions – genetic and otherwise – for developing cancer?  [Read More](https://blog.canceriq.com/press/canceriq-ceo-feyi-olopade-featured-alumni-at-st.-pauls-school) ## [CancerIQ Wins at the Chicago Innovation Awards](https://blog.canceriq.com/press/canceriq-wins-at-the-chicago-innovation-awards) [![](https://blog.canceriq.com/hubfs/Social%20media.png) ](https://blog.canceriq.com/press/canceriq-wins-at-the-chicago-innovation-awards)  **October 25, 2016– Chicago, IL—** [CancerIQ](https://www.canceriq.com/),  a digital health company that uses predictive analytics to help doctors understand their patient's risk of getting cancer and dying from cancer, was named a winner at the [15th annual Chicago Innovation Awards](http://www.chicagoinnovationawards.com/winners/up-and-comers/) for its flagship product, CancerIQ Risk software. [Read More](https://blog.canceriq.com/press/canceriq-wins-at-the-chicago-innovation-awards) ## [CancerIQ One of Four Companies using Health IT in Genetic Testing](https://blog.canceriq.com/press/medcity-news-four-companies-using-health-it-to-support-a-genetic-test-management-infrastructure) [![](https://blog.canceriq.com/hubfs/medcity.png) ](https://blog.canceriq.com/press/medcity-news-four-companies-using-health-it-to-support-a-genetic-test-management-infrastructure) **September 7, 2016– **[CancerIQ is featured along with NextGxDx, NantHealth and Health Gorilla as companies that are developing health technology services to address the growth in genetic testing.](http://medcitynews.com/2016/09/4-companies-making-genetic-testing-data-actionable/) [Read More](https://blog.canceriq.com/press/medcity-news-four-companies-using-health-it-to-support-a-genetic-test-management-infrastructure) ## [CancerIQ Named Top 100 Finalist for Chicago Innovation Awards](https://blog.canceriq.com/press/canceriq-is-named-one-of-the-top-100-finalists-for-the-15th-annual-chicago-innovation-awards) [![](https://blog.canceriq.com/hubfs/chicago_innovation_awards.jpg) ](https://blog.canceriq.com/press/canceriq-is-named-one-of-the-top-100-finalists-for-the-15th-annual-chicago-innovation-awards) **** **September 15, 2016 – Chicago, IL— **Out of 643 nominees, CancerIQ of Chicago, IL** **has been selected as one of the Top 100 Finalists for the 15th annual Chicago Innovation Awards. The awards celebrate the most innovative new products and services in the Chicago region across all organization sizes, sectors and industries. On October 25th, 1500 business and civic leaders will come together to honor the winners when they are announced at Chicago’s Harris Theater. [Read More](https://blog.canceriq.com/press/canceriq-is-named-one-of-the-top-100-finalists-for-the-15th-annual-chicago-innovation-awards) ## [CancerIQ CEO, Feyi Olopade Ayodele, featured MATTER member](https://blog.canceriq.com/press/canceriq-ceo-feyi-olopade-ayodele-featured-matter-member) [![](https://blog.canceriq.com/hubfs/MATTER-Logo_1252px.jpg) ](https://blog.canceriq.com/press/canceriq-ceo-feyi-olopade-ayodele-featured-matter-member) **August 31, 2016–** The first light bulb went off on Mt. Kilimanjaro. It was 2012, and Feyi Olopade Ayodele was standing on the mythic African peak with her mother, Dr. Funmi Olopade, an award-winning cancer researcher from the University of Chicago. Feyi – who then focused on making early stage investments in healthcare startups at the Wharton Social Venture Fund – was in the middle of a career crisis. “I was feeling a lot like Simon Cowell at the time,” she confesses. [Read More](https://blog.canceriq.com/press/canceriq-ceo-feyi-olopade-ayodele-featured-matter-member) ## [CancerIQ Ranked As Top Chicago Startup by Symmetry 50](https://blog.canceriq.com/press/canceriq-ranked-as-top-chicago-startup-by-symmetry-50) [![](https://blog.canceriq.com/hubfs/Screen_Shot_2016-08-23_at_1.12.55_PM.png) ](https://blog.canceriq.com/press/canceriq-ranked-as-top-chicago-startup-by-symmetry-50) **December 1, 2014– **[CancerIQ](https://www.canceriq.com/) is honored to be ranked #10 on the [Top 75 C](http://www.symmetry50.com/blog/2014/11/17/the-top-startups-in-chicago)hicago Startups list ranked by Symmetry50. CancerIQ joins other startups such as Scout, a home security system and FoodGenius, data analytics for the food industry, on the list. [Read More](https://blog.canceriq.com/press/canceriq-ranked-as-top-chicago-startup-by-symmetry-50) ## [CancerIQ joins new Chicago healthcare startup incubator](https://blog.canceriq.com/press/canceriq-joins-new-chicago-healthcare-startup-incubator) [![](https://blog.canceriq.com/hubfs/MATTER-Logo_1252px.jpg) ](https://blog.canceriq.com/press/canceriq-joins-new-chicago-healthcare-startup-incubator) **Octover 28, 2014–** It was recently announced that[CancerIQ](https://www.canceriq.com/) will be one of 10 healthcare startups working in[MATTER](http://matterchicago.com/)–  a new healthcare technology hub in Chicago.  CancerIQ will join a group of 9 other next-generation companies focused on health IT, medical devices, diagnostics and biopharma.  [Read More](https://blog.canceriq.com/press/canceriq-joins-new-chicago-healthcare-startup-incubator) ## [CancerIQ one of 10 Chicago startups likely to change healthcare](https://blog.canceriq.com/press/canceriq-one-of-10-chicago-startups-likely-to-change-healthcare) [![](https://blog.canceriq.com/hubfs/chicago-sun-times-logo.png) ](https://blog.canceriq.com/press/canceriq-one-of-10-chicago-startups-likely-to-change-healthcare) **October 28, 2016– **[CancerIQ](https://www.canceriq.com/) is part of a new crop of healthcare startups to find a home at soon-to-be opened healthcare startup hub [MATTER](http://matterchicago.com/). The space will feature companies from across healthcare– diagnostics, biopharma, health IT and medical devices.  [Read More](https://blog.canceriq.com/press/canceriq-one-of-10-chicago-startups-likely-to-change-healthcare) ## [CancerIQ One of First Ten at Matter](https://blog.canceriq.com/press/chicago-health-startup-hub-picks-first-ten-companies) [![](https://blog.canceriq.com/hubfs/MATTER-Logo_1252px.jpg) ](https://blog.canceriq.com/press/chicago-health-startup-hub-picks-first-ten-companies) **October 28, 2014–** Health-tech incubator, Matter recently announced the first 10 startup companies to call their offices home. [CancerIQ](https://www.canceriq.com/) joins 9 other companies including a "specialty pharmaceutical company, a creator of a blood-sampling system and a company that integrates robotics with heart procedures." [Read More](https://blog.canceriq.com/press/chicago-health-startup-hub-picks-first-ten-companies) ## [CancerIQ puts spotlight on Chicago startup scene](https://blog.canceriq.com/press/canceriq-puts-spotlight-on-chicago-startup-scene) [![](https://blog.canceriq.com/hubfs/Screen_Shot_2016-08-23_at_1.55.51_PM.png) ](https://blog.canceriq.com/press/canceriq-puts-spotlight-on-chicago-startup-scene) **September 29, 2014–** Next month, Chicago will be one of 16 cities to host Challenge Cup, a global startup competition. The competition is in 11 countries and offers $650,000 in prizes to health, education, energy and civic tech startups.  [Read More](https://blog.canceriq.com/press/canceriq-puts-spotlight-on-chicago-startup-scene) [Previous](https://blog.canceriq.com/press/author/canceriq/page/1) [All posts](https://blog.canceriq.com/press/all) [Next](https://blog.canceriq.com/press/author/canceriq/page/3) ![CancerIQ Logo 3](https://blog.canceriq.com/hubfs/CancerIQ-July2016-Images/CancerIQ_Logo_AL_03-e1445840775293.png) CancerIQ makes it easy for providers to offer genetic cancer risk assessment programming to every patient that walks through the door. Our suite of patient engagement tools and productivity solutions make it easy for any busy healthcare system to start, run, and grow a highly impactful cancer risk program at lower costs. ### Contact Us Please feel free to reach out to us: **515 N. State, Suite 1075, Chicago, 60654 Illinois **+312-761-3360 ** info@cancer-iq.com Cancer IQ, Inc. 2019